首页 | 本学科首页   官方微博 | 高级检索  
检索        

奥沙利铂联合卡培他滨行新辅助化疗治疗进展期胃癌30例疗效观察
引用本文:傅炯.奥沙利铂联合卡培他滨行新辅助化疗治疗进展期胃癌30例疗效观察[J].中国现代医生,2011,49(21):61-62.
作者姓名:傅炯
作者单位:浙江省奉化市人民医院普外肿瘤科,浙江奉化,315500
摘    要:目的探讨奥沙利铂联合卡培他滨行新辅助化疗治疗进展期胃癌的疗效。方法60例进展期胃癌患者分为对照组和观察组各30例,对照组采用ECF化疗方案进行围手术期化疗,观察组采用奥沙利铂联合卡培他滨进行围手术期化疗。结果观察组总有效率高于对照组,但无显著性差异(P〉0.05);观察组骨髓抑制、胃肠道反应发生率低于对照组(P〈0.05);两组患者达到根治效果(D2+D1)的比率有显著性差异(P〈0.05),两组1年生存率有显著性差异(P〈0.05),观察组均高于对照组。结论奥沙利铂联合卡培他滨对进展期胃癌行围手术期化疗,其术前化疗总有效率、肿瘤手术切除率、根治切除率、患者1年生存率均高于ECF化疗方案,毒副反应显著低于ECF化疗方案。

关 键 词:进展期胃癌  新辅助化疗  5-氟尿嘧啶  卡培他滨  奥沙利铂

Oxaliplatin Combined with Capecitabine Neoadjuvant Chemotherapy Line Treatment of Advanced Gastric Cancer: An Effect Observation of 30 Cases
Authors:FU Jiong
Institution:FU Jiong General Surgery and Oncology Department,Fenghua City People's Hospital,Fenghua 315500,China
Abstract:Objective Capecitabine combined with oxaliplatin neoadjuvant chemotherapy line treatment of advanced gastric cancer patients.Methods Sixty patients with advanced gastric cancer patients were divided into control group and observation group of 30 patients in the control group were treated with chemotherapy regimen ECF perioperative chemotherapy group were observed with oxaliplatin combined with capecitabine for perioperative chemotherapy.Results The total effective rate higher than observed,but no significan...
Keywords:Advanced gastric cancer  Neoadjuvant chemotherapy  5-fluorouracil  Capecitabine  Oxaliplatin  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号